Irisin improves delayed bone repair in diabetic female mice
暂无分享,去创建一个
Y. Tabata | J. Jo | Yuya Mizukami | N. Kawao | K. Okumoto | H. Kaji | Yoshimasa Takafuji | Hiroki Ehara | Yuko Kinoshita | Yuto Takada
[1] Yuya Mizukami,et al. Renal failure suppresses muscle irisin expression, and irisin blunts cortical bone loss in mice , 2022, Journal of cachexia, sarcopenia and muscle.
[2] E. Morgan,et al. Roles and Mechanisms of Irisin in Attenuating Pathological Features of Osteoarthritis , 2021, Frontiers in Cell and Developmental Biology.
[3] Katsu Takahashi,et al. Local application of Usag-1 siRNA can promote tooth regeneration in Runx2-deficient mice , 2021, Scientific Reports.
[4] Yuya Mizukami,et al. Role of irisin in effects of chronic exercise on muscle and bone in ovariectomized mice , 2021, Journal of Bone and Mineral Metabolism.
[5] Yiqi Yang,et al. Irisin inhibits osteocyte apoptosis by activating the Erk signaling pathway in vitro and attenuates ALCT-induced osteoarthritis in mice. , 2020, Bone.
[6] B. Spiegelman,et al. Irisin directly stimulates osteoclastogenesis and bone resorption in vitro and in vivo , 2020, bioRxiv.
[7] Dongjun Liu,et al. Cleavage of FNDC5 and insights into its maturation process , 2020, Molecular and Cellular Endocrinology.
[8] K. Okada,et al. PAI-1 is involved in delayed bone repair induced by glucocorticoids in mice. , 2020, Bone.
[9] Chaofei Yang,et al. Recombinant Irisin Prevents the Reduction of Osteoblast Differentiation Induced by Stimulated Microgravity through Increasing β-Catenin Expression , 2020, International journal of molecular sciences.
[10] S. Colucci,et al. Irisin Prevents Disuse‐Induced Osteocyte Apoptosis , 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[11] M. Akagi,et al. Role of irisin in androgen-deficient muscle wasting and osteopenia in mice , 2019, Journal of Bone and Mineral Metabolism.
[12] X. Qiao,et al. Lower circulating irisin in middle-aged and older adults with osteoporosis: a systematic review and meta-analysis. , 2019, Menopause.
[13] Rui Li,et al. Irisin Is Controlled by Farnesoid X Receptor and Regulates Cholesterol Homeostasis , 2019, Front. Pharmacol..
[14] Xinquan Jiang,et al. Delivery vehicle of muscle-derived irisin based on silk/calcium silicate/sodium alginate composite scaffold for bone regeneration , 2019, International journal of nanomedicine.
[15] B. Spiegelman,et al. Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors , 2018, Cell.
[16] Yaxian Ma,et al. Irisin promotes proliferation but inhibits differentiation in osteoclast precursor cells , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[17] K. Okada,et al. Role of Macrophages and Plasminogen Activator Inhibitor-1 in Delayed Bone Repair in Diabetic Female Mice. , 2018, Endocrinology.
[18] Xu Zhou,et al. Association of Plasma Irisin with Bone Mineral Density in a Large Chinese Population Using an Extreme Sampling Design , 2018, Calcified Tissue International.
[19] K. Okada,et al. Role of plasminogen activator inhibitor ‐ 1 in glucocorticoid ‐ induced muscle change in mice , 2017 .
[20] N. Kawao,et al. Roles of Irisin in the Linkage from Muscle to Bone During Mechanical Unloading in Mice , 2018, Calcified Tissue International.
[21] Jiake Xu,et al. TNF-α inhibits SATB2 expression and osteoblast differentiation through NF-κB and MAPK pathways , 2017, Oncotarget.
[22] J. Reseland,et al. Irisin prevents and restores bone loss and muscle atrophy in hind-limb suspended mice , 2017, Scientific Reports.
[23] D. Jiang,et al. High glucose‐induced LIF suppresses osteoblast differentiation via regulating STAT3/SOCS3 signaling , 2017, Cytokine.
[24] N. Kawao,et al. Vitamin D deficiency aggravates diabetes-induced muscle wasting in female mice , 2017, Diabetology International.
[25] H. Kaji. Effects of myokines on bone. , 2016, BoneKEy reports.
[26] B. Olsen,et al. Osteoblast-derived VEGF regulates osteoblast differentiation and bone formation during bone repair. , 2016, The Journal of clinical investigation.
[27] R. Cheng,et al. Irisin promotes osteoblast proliferation and differentiation via activating the MAP kinase signaling pathways , 2016, Scientific Reports.
[28] T. Yuen,et al. The myokine irisin increases cortical bone mass , 2015, Proceedings of the National Academy of Sciences.
[29] Qian Zhao,et al. Decreased irisin secretion contributes to muscle insulin resistance in high-fat diet mice. , 2015, International journal of clinical and experimental pathology.
[30] P. Matafome,et al. Irisin and Myonectin Regulation in the Insulin Resistant Muscle: Implications to Adipose Tissue: Muscle Crosstalk , 2015, Journal of diabetes research.
[31] N. Kawao,et al. Interactions Between Muscle Tissues and Bone Metabolism , 2015, Journal of cellular biochemistry.
[32] Y. Chiba,et al. Role of PlasminogenActivator Inhibitor-1 in Glucocorticoid-Induced Diabetes and Osteopenia in Mice , 2015 .
[33] K. Okada,et al. Plasminogen Activator Inhibitor-1 Is Involved in Impaired Bone Repair Associated with Diabetes in Female Mice , 2014, PloS one.
[34] C. Mantzoros,et al. Circulating irisin is associated with osteoporotic fractures in postmenopausal women with low bone mass but is not affected by either teriparatide or denosumab treatment for 3 months , 2014, Osteoporosis International.
[35] S. Colucci,et al. Irisin Enhances Osteoblast Differentiation In Vitro , 2014, International journal of endocrinology.
[36] I. Kanazawa,et al. Advanced glycation end products suppress osteoblastic differentiation of stromal cells by activating endoplasmic reticulum stress. , 2013, Biochemical and biophysical research communications.
[37] Lutz Claes,et al. Fracture healing under healthy and inflammatory conditions , 2012, Nature Reviews Rheumatology.
[38] B. Spiegelman,et al. A PGC1α-dependent myokine that drives browning of white fat and thermogenesis , 2012, Nature.
[39] J. J. Swaroop,et al. Association of TNF-α with insulin resistance in type 2 diabetes mellitus , 2012, The Indian journal of medical research.
[40] N. Donos,et al. The effect of diabetes mellitus on osseous healing. , 2010, Clinical oral implants research.
[41] L. McCabe. Understanding the pathology and mechanisms of type I diabetic bone loss , 2007, Journal of cellular biochemistry.
[42] P. Vestergaard,et al. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis , 2007, Osteoporosis International.
[43] Sheldon S. Lin,et al. The effects of local insulin delivery on diabetic fracture healing. , 2005, Bone.
[44] Shingo,et al. A PGC1-\(\alpha\)-dependent Myokine that Drives Brown-fat-like Development of White Fat and Thermogenesis , 2012 .
[45] C. Ackert-Bicknell,et al. Marrow fat and the bone microenvironment: developmental, functional, and pathological implications. , 2009, Critical reviews in eukaryotic gene expression.